This Oral Drug Could Slow Down Brain Tumour: What We Know

The experimental drug can slow down the progression of a brain tumour for up to 27 months, said the drug's developer

An experimental drug developed by French drug developer Servier, called 'Vorasidenib', can significantly slow down the progression of a brain tumour, said the company.

The targeted therapy drug called Vorasidenib showed noteworthy effects by delaying the progression of a brain tumour, according to the study published in the New England Journal of Medicine.